rules for prescribing Wellbutrin

If you’re struggling with Binge Eating Disorder (BED), you’ve probably wondered whether you can get help—and medication—without visiting a doctor’s office in person. The short answer is yes. Thanks to expanded telehealth regulations and the permanent shift toward virtual care, accessing evidence-based treatment for BED through telemedicine is not only possible but increasingly common across the United States.

This comprehensive guide will walk you through everything you need to know about getting BED medication via telehealth in 2026: what’s legal, which medications are available, how the process works, and what to watch out for when choosing a provider.

Understanding Binge Eating Disorder and Why Medication Matters

Binge Eating Disorder is the most common eating disorder in the United States, affecting millions of Americans. It’s characterized by recurrent episodes of eating large quantities of food in a short period (typically within two hours), accompanied by a feeling of loss of control. Unlike bulimia, BED doesn’t involve purging behaviors like vomiting or excessive exercise.

To meet the clinical criteria for BED according to DSM-5, you must experience binge eating episodes at least once a week for three months, along with marked distress about the behavior. The diagnosis doesn’t depend on your weight or appearance—people of all body sizes can have BED.

While psychotherapy (particularly Cognitive Behavioral Therapy) remains the gold standard for BED treatment, medication can play an important supporting role. Some patients benefit significantly from pharmacological interventions that help reduce binge frequency, improve impulse control, and address co-occurring conditions like depression or anxiety.

Free consultations available with select providers only.

Get a free consultation

And find an affordable, caring specialist.

Find a provider

Free consultations available with select providers only.

The Telehealth Revolution: What Changed and What Stayed

The COVID-19 pandemic accelerated telehealth adoption across healthcare, and mental health and eating disorder treatment were no exceptions. Emergency waivers allowed providers to prescribe medications via video visits without the in-person requirements that previously existed for some drugs.

Here’s what you need to know about the current landscape:

Federal Rules for Non-Controlled Medications

Medications like Topamax (topiramate) and Wellbutrin (bupropion)—two commonly prescribed off-label treatments for BED—are not controlled substances. This is crucial because the strict federal telehealth prescribing rules (the Ryan Haight Act) only apply to controlled medications like stimulants or opioids.

For non-controlled medications, there has never been a federal requirement for an in-person visit before prescribing via telehealth. These medications can be legally prescribed through telehealth appointments in all 50 states, as long as the provider is licensed in your state and follows appropriate standards of care.

What About Controlled Substances?

The only FDA-approved medication specifically for BED is Vyvanse (lisdexamfetamine), a controlled stimulant. Telehealth rules for controlled substances are more complex. The DEA extended pandemic-era flexibilities through December 31, 2026, allowing providers to prescribe certain controlled medications via telehealth without an initial in-person visit.

However, most reputable telehealth platforms don’t prescribe stimulants like Vyvanse for BED due to abuse potential and stricter oversight requirements. Instead, they focus on non-controlled alternatives that have shown effectiveness in clinical studies.

Medications Available for BED via Telehealth

Let’s examine the two most common non-controlled medications prescribed for Binge Eating Disorder through telehealth platforms:

Topamax (Topiramate)

What it is: Originally approved for seizure disorders and migraine prevention, topiramate is frequently prescribed off-label for BED.

How it works: Topiramate may help reduce binge eating episodes by affecting neurotransmitters involved in impulse control and appetite regulation. Clinical studies have shown it can decrease binge frequency and support weight management in some patients.

Typical dosing: Treatment usually starts at a low dose (25mg) and gradually increases to minimize side effects. Most patients take between 50-200mg daily.

Important considerations:

• Not safe during pregnancy: Topiramate is associated with increased risk of birth defects, including cleft palate. Women of childbearing age must use effective contraception.
• Cognitive side effects: Some patients experience ‘brain fog,’ difficulty finding words, or concentration problems, especially at higher doses.
• Gradual discontinuation required: Never stop topiramate suddenly, as this can trigger seizures. Always taper under medical supervision.

Telehealth availability: Fully available via telehealth in all states with no in-person visit required in most jurisdictions. Prescriptions can typically include up to 90-day supplies with refills.

Wellbutrin (Bupropion)

What it is: An antidepressant also approved for smoking cessation, bupropion is commonly prescribed off-label for BED.

How it works: Bupropion affects dopamine and norepinephrine pathways, which may help reduce the rewarding aspects of binge eating and improve mood regulation. Research suggests it can decrease binge frequency in many patients.

Typical dosing: Usually started at 150mg daily (extended-release formulation), potentially increasing to 300-450mg depending on response and tolerability.

Important considerations:

• Seizure risk: Bupropion lowers the seizure threshold and is contraindicated in patients with current or past eating disorders involving purging (bulimia or anorexia nervosa), as these conditions increase seizure risk.
• Alcohol interaction: Avoid alcohol while taking bupropion due to increased seizure risk.
• Black box warning: Like all antidepressants, bupropion carries a warning about increased suicidal thoughts in young adults under 25. Close monitoring is essential, especially when starting treatment.
• Blood pressure monitoring: Can raise blood pressure in some patients, particularly when combined with other medications.

Telehealth availability: Fully available via telehealth nationwide. Prescriptions can include refills for up to one year in most states.

State-by-State Telehealth Rules: What You Need to Know

While federal law doesn’t restrict telehealth prescribing of non-controlled medications, individual states have varying requirements. Here’s what matters for patients seeking BED treatment:

No In-Person Visit Required (Most States)

California, New York, Texas, Florida, Delaware, Michigan, Wisconsin, South Carolina and many others have no state requirement for an initial in-person visit before prescribing non-controlled medications via telehealth. A comprehensive video evaluation that meets the standard of care is sufficient.

California even went further in 2025 with legislation (AB 1503) clarifying that asynchronous telehealth (online questionnaires combined with provider review) can constitute an appropriate exam for certain conditions when clinically appropriate.

Periodic In-Person Follow-Up Required (Select States)

A handful of states require periodic in-person visits for ongoing telehealth care:

Alabama: After four telehealth visits for the same condition within 12 months, patients must have an in-person visit within that year. This can be satisfied by seeing any healthcare provider (doesn’t have to be the prescribing telehealth doctor).

Georgia: Requires attempting an in-person examination at least annually for continuing telemedicine relationships, though the initial evaluation can be done via telehealth if clinically appropriate.

New Hampshire: For controlled substances (Schedules II-IV), an in-person follow-up is required within 12 months. For non-controlled medications like those used for BED, no such requirement exists, though best practices suggest periodic in-person care.

Provider Licensing Requirements

Your telehealth provider must be licensed in the state where you’re physically located during the appointment. This is non-negotiable. Reputable platforms verify your location at the start of each visit and ensure they only connect you with appropriately licensed clinicians.

Who Can Prescribe BED Medications via Telehealth?

Several types of healthcare providers can evaluate and prescribe medications for Binge Eating Disorder through telehealth:

Physicians (MDs and DOs)

Doctors can prescribe these medications in all states via telehealth without restrictions (aside from general state telehealth requirements).

Nurse Practitioners (NPs)

As of 2025, 34 states plus Washington D.C. grant Nurse Practitioners full practice authority, meaning they can diagnose, treat, and prescribe medications independently without physician oversight. This includes states like California, New York, Massachusetts, Connecticut, New Hampshire, Michigan, and Wisconsin.

Several states joined this list in 2023-2025, including Louisiana, Kansas, Wisconsin, and Michigan, reflecting a national trend toward expanding NP autonomy.

In states without full practice authority (like Texas, Florida, Georgia, and Alabama), NPs can still prescribe non-controlled medications like Topamax and Wellbutrin, but they must work under a collaborative agreement with a physician. From your perspective as a patient, this typically doesn’t affect your care—it’s a behind-the-scenes regulatory requirement.

Physician Assistants (PAs)

PAs can prescribe these medications in all states, though they generally work under physician supervision. The level of autonomy varies by state, but practically speaking, PAs at established telehealth platforms can evaluate and prescribe BED medications just like other providers.

The Telehealth Evaluation Process: What to Expect

Understanding what happens during a telehealth appointment for BED helps you prepare and ensures you receive quality care:

Initial Assessment (30-60 minutes)

A thorough initial evaluation is essential and typically includes:

Medical history review:

• Current and past medical conditions
• All medications and supplements you’re taking
• Previous treatments for BED or other eating disorders
• Mental health history, including depression, anxiety, or trauma
• Substance use history
• Seizure history (critical for medication safety)
• Pregnancy status and contraception methods

Eating disorder assessment:

• Detailed questions about binge eating patterns
• Frequency and duration of episodes
• Triggers and emotional states associated with binges
• Compensatory behaviors (to rule out bulimia)
• Impact on daily functioning and quality of life
• Previous eating disorder treatment

Screening tools: Many providers use standardized questionnaires like the Binge Eating Scale (BES) or Eating Disorder Examination Questionnaire (EDE-Q) to objectively assess symptom severity.

Safety screening: Providers will screen for contraindications to medication, including:

• History of seizures or epilepsy
• Past or current bulimia or anorexia (contraindication for bupropion)
• Pregnancy or breastfeeding plans
• Medications that might interact (especially other antidepressants, MAO inhibitors, or medications lowering seizure threshold)

Identity and Location Verification

Don’t be surprised when your provider asks to verify your identity and location. This isn’t invasive—it’s required by many state laws and ensures the provider is licensed to treat you. You may need to show your driver’s license and confirm your current address.

Treatment Planning and Informed Consent

If medication is appropriate, your provider will:

• Explain why they’re recommending a specific medication
• Discuss the off-label nature of the prescription (since neither medication is FDA-approved specifically for BED)
• Review potential side effects and how to manage them
• Outline the dosing schedule and titration plan
• Discuss what to do if side effects occur
• Explain follow-up requirements
• Answer all your questions

You’ll sign an informed consent document acknowledging you understand the treatment plan, including the off-label use of medication.

Prescription Process

Your provider will electronically send the prescription to your chosen pharmacy. You should receive it within hours. For medications like topiramate or bupropion, you’ll pick them up at a regular retail or mail-order pharmacy—never accept medications shipped directly from a telehealth company’s own warehouse, as this bypasses important safety checks.

Follow-Up Schedule

Expect regular follow-up appointments, especially initially:

• 2-week check-in: To assess initial tolerability and side effects
• Monthly visits (first 3 months): To monitor response, adjust dosing, and ensure safety
• Ongoing care (every 2-3 months): Once stable, to maintain treatment effectiveness

How Klarity Health Supports Your BED Treatment Journey

At Klarity Health, we understand that getting help for Binge Eating Disorder shouldn’t mean navigating a maze of regulations, scheduling conflicts, and limited provider availability. Our telehealth platform is designed to make evidence-based BED treatment accessible, affordable, and straightforward.

Provider Availability When You Need It

Unlike traditional clinics where you might wait weeks or months for an appointment with an eating disorder specialist, Klarity Health connects you with licensed healthcare providers who have experience treating BED—often within days. Our network includes MDs, DOs, and NPs licensed in your state, ensuring you receive care from qualified professionals who understand the complexity of eating disorders.

Transparent Pricing You Can Plan Around

Healthcare costs shouldn’t be a mystery. Klarity Health offers clear, upfront pricing for all services. We accept both insurance and cash pay options, giving you flexibility based on your situation. Our team can verify your insurance benefits before your first appointment, so you know exactly what to expect.

Comprehensive Care Beyond Medication

While medication can be an important tool, we recognize that BED treatment works best with a holistic approach. Klarity Health providers can coordinate with therapists, registered dietitians, and other specialists to ensure you receive comprehensive care. We’re not just a prescription service—we’re a partner in your recovery journey.

Red Flags: What to Watch Out for in Telehealth Services

The explosion of telehealth options means patients need to be discerning consumers. Here are warning signs of low-quality or potentially unsafe telehealth services:

Prescription Promises Before Evaluation

Any service that guarantees you’ll receive a prescription before you’ve even had an assessment is violating medical ethics and likely state laws. Legitimate providers conduct thorough evaluations and may determine that medication isn’t appropriate for you—and that’s okay.

Minimal Assessment Process

If the ‘evaluation’ consists of a five-minute questionnaire with yes/no answers and no actual conversation with a provider, that’s inadequate. States like Georgia explicitly require that telehealth exams meet the same standard of care as in-person visits.

Selling Medications Directly

Reputable telehealth platforms send prescriptions to licensed pharmacies, where you pick up FDA-approved medications. If a company wants to ship you pills from their own facility without using a pharmacy, that’s a major red flag for counterfeit or compounded medications of questionable quality.

No Discussion of Alternatives

Standard care for BED includes psychotherapy, nutritional counseling, and support groups in addition to or instead of medication. If a provider doesn’t mention these options or discuss a comprehensive treatment plan, they’re not providing appropriate care.

Unrealistic Dosing

Starting medications at maximum doses, prescribing multiple new medications simultaneously, or failing to discuss titration schedules suggests dangerous practices. Safe prescribing starts low and increases gradually.

Poor Follow-Up Systems

Legitimate telehealth services have clear systems for follow-up appointments, medication monitoring, and emergency contact. If there’s no plan for ongoing care or you can’t reach anyone with questions, look elsewhere.

Who Shouldn’t Pursue Telehealth Treatment for BED?

While telehealth expands access significantly, some patients need in-person care:

Medical Complexity Requiring Physical Examination

If you have severe metabolic complications from BED, uncontrolled diabetes with frequent hypoglycemia, cardiovascular instability, or other conditions requiring hands-on physical assessment, you may need initial in-person evaluation before transitioning to telehealth for ongoing care.

Active Purging Behaviors

If you’re experiencing binge eating and purging (vomiting, laxative abuse, excessive exercise), you likely have bulimia nervosa rather than BED. Bupropion is contraindicated in these cases due to seizure risk, and you need more intensive, specialized care that may require in-person treatment.

Current Pregnancy or Immediate Pregnancy Plans

Topiramate poses significant fetal risks and should not be used during pregnancy. While providers can prescribe other options, pregnancy often warrants in-person eating disorder care given the complex nutritional needs and monitoring requirements.

Severe Mental Health Crises

If you’re experiencing active suicidal ideation, severe depression requiring hospitalization, or other psychiatric emergencies, telehealth alone is insufficient. Seek immediate in-person care through an emergency department or crisis center.

Preference for Controlled Medications

If you’ve tried non-controlled options without success and believe you need Vyvanse (the only FDA-approved BED medication, which is a controlled stimulant), you’ll likely need to establish care with an in-person provider, as most telehealth platforms don’t prescribe controlled substances for BED.

Insurance Coverage and Cost Considerations

Most health insurance plans now cover telehealth visits at the same rate as in-person appointments, thanks to policy changes that outlasted the COVID-19 public health emergency. However, coverage specifics vary:

Commercial Insurance

Most private insurance plans cover telehealth mental health and psychiatric visits. Your copay for a telehealth appointment should match what you’d pay for an office visit. Medication coverage depends on your pharmacy benefit—topiramate and bupropion are typically well-covered as generic medications.

Medicare

Medicare continues to cover many telehealth services post-pandemic, though coverage rules have been extended through temporary legislative actions (currently through 2026). Medicare Advantage plans often have even broader telehealth benefits.

Medicaid

Medicaid telehealth coverage varies significantly by state. Many states permanently adopted expanded telehealth coverage after the pandemic. Check your state’s Medicaid program for specific details.

Cash Pay Options

For those without insurance or preferring not to use it, cash pay options provide an alternative. At Klarity Health, we offer transparent cash pricing that’s often competitive with insurance copays, especially for high-deductible plans.

The Future of Telehealth for Eating Disorders

The regulatory landscape continues to evolve, generally in the direction of expanded access:

Permanent Federal Flexibilities

While controlled substance prescribing rules remain in temporary extension status (through December 31, 2026), there’s growing bipartisan support for making telehealth flexibilities permanent. Congressional proposals would solidify patients’ ability to access mental health care remotely.

State-Level Expansion

The trend at the state level is toward fewer restrictions. Recent changes in states like Wisconsin, Michigan, and New Hampshire reflect recognition that telehealth can safely expand access without compromising quality when appropriate guardrails exist.

Technology Integration

Expect to see more sophisticated remote monitoring tools, including:

• Apps that track eating patterns and moods
• Integration with wearable devices for physiological monitoring
• AI-assisted screening tools to identify high-risk patients
• Virtual group therapy options for BED support

Quality Standards Enforcement

Recent enforcement actions against unsafe telehealth providers (like the indictment of executives from a startup that overprescribed ADHD stimulants without proper evaluation) demonstrate that regulators are actively policing the telehealth space. This is ultimately good for patients, as it weeds out bad actors while preserving access through legitimate services.

Taking the First Step: How to Get Started

If you think you might have Binge Eating Disorder and want to explore telehealth treatment:

1. Self-assessment: Honestly evaluate your symptoms against the DSM-5 criteria. Are you experiencing recurrent episodes of eating large amounts of food with loss of control, at least weekly, for three months or more?

2. Document your history: Before your appointment, write down:

• All current medications and supplements
• Relevant medical history (especially seizures, eating disorders, mental health conditions)
• Your eating patterns and triggers
• Previous treatments you’ve tried

3. Choose a reputable provider: Look for platforms with licensed providers, clear pricing, established follow-up systems, and positive reviews from verified patients. Klarity Health meets all these criteria and specializes in mental health and eating disorder care.

4. Prepare questions: Write down what you want to know about:

• Medication options and their side effects
• Expected timeline for improvement
• Therapy recommendations
• What to do if you have problems between appointments

5. Schedule your appointment: Most telehealth platforms offer online scheduling 24/7. Choose a time when you can have privacy and won’t be rushed.

6. Follow through with treatment: Medication works best when combined with consistent follow-up, therapy, and lifestyle modifications. Commit to the process, attend follow-up appointments, and communicate openly with your provider.

Conclusion: Access to Care Is Here

The expansion of telehealth has fundamentally changed access to Binge Eating Disorder treatment. What once required months-long waits for specialist appointments, taking time off work, and navigating limited local resources can now happen from your home within days.

The regulations supporting this access are stable and likely to become even more patient-friendly. For non-controlled medications like topiramate and bupropion—the mainstays of pharmacological BED treatment—there are virtually no federal or state barriers to telehealth prescribing in 2026.

At the same time, patients must be informed consumers. Understanding what quality care looks like, knowing the warning signs of unsafe practices, and working with reputable providers ensures you receive safe, effective treatment.

If Binge Eating Disorder is affecting your health, relationships, or quality of life, you don’t have to struggle alone or wait months for help. Telehealth makes evidence-based treatment accessible today. With the right provider, appropriate medication, and comprehensive support, recovery is absolutely possible.

Ready to take the next step? Klarity Health offers convenient appointments with licensed providers who specialize in eating disorders and mental health treatment. Our transparent pricing, flexible scheduling, and commitment to quality care make getting help straightforward and affordable. Schedule your confidential evaluation today and start your journey toward a healthier relationship with food.

Research Currency Statement

Verified as of: January 4, 2026

DEA Rules Status: COVID-19 telehealth prescribing flexibilities remain in effect through December 31, 2026 (fourth extension). No federal in-person requirement exists for non-controlled medications—these were never subject to the Ryan Haight Act restrictions on telemedicine.

States Verified: Researched 10+ key states (AL, CA, DE, FL, GA, NH, NY, TX, MI, WI, etc.) with latest information as of late 2025. State board sites and 2025 legislative updates were checked where available.

Sources newer than 2024: 80%+ of sources are from 2025 (many late-2025) or updated to 2025. Older sources (2024) were used only when confirmed still accurate by newer references.

⚠️ Flagged for follow-up: Alabama and South Carolina NP scope changes (legislation was discussed in 2025 but final status unclear—assume no full independence yet pending confirmation). Monitor DEA’s pending final rule on telehealth prescribing (expected by end of 2026). Verify any temporary state waivers for expiration/extension beyond 2025.

References

1. U.S. Department of Health and Human Services. (2026). DEA extends telemedicine prescribing flexibilities through December 31, 2026. Retrieved from https://www.hhs.gov/press-room/dea-telemedicine-extension-2026.html

2. Sheppard Mullin Richter & Hampton LLP. (2025). Telehealth and in-person visits: Tracking federal and state updates to pandemic-era telehealth exceptions. Retrieved from https://www.sheppardhealthlaw.com/2025/08/articles/telehealth/telehealth-and-in-person-visits-tracking-federal-and-state-updates-to-pandemic-era-telehealth-exceptions/

3. Center for Connected Health Policy. (2025). State telehealth laws and reimbursement policies: Online prescribing. Retrieved from https://www.cchpca.org/topic/online-prescribing/

4. Health Jobs Nationwide. (2025). State-by-state guide: Expanding roles for PAs and NPs (Updated 2025). Retrieved from https://blog.healthjobsnationwide.com/state-by-state-guide-expanding-roles-for-pas-and-nps-updated-2025/

5. DailyMed, National Library of Medicine. Bupropion hydrochloride extended-release tablets prescribing information. Retrieved from https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=1b69c253-4740-44b0-be63-6c20834540b6&type=display

This article is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider regarding diagnosis and treatment of Binge Eating Disorder or any other medical condition.

Source:

• https://www.hhs.gov/press-room/dea-telemedicine-extension-2026.html#:~:text=patients%20to%20receive%20prescriptions%20for,while%20permanent%20rules%20are%20finalized
• https://www.sheppardhealthlaw.com/2025/08/articles/telehealth/telehealth-and-in-person-visits-tracking-federal-and-state-updates-to-pandemic-era-telehealth-exceptions/#:~:text=extended%20telemedicine%20prescribing%20waivers%20through,prescribing
• https://blog.healthjobsnationwide.com/state-by-state-guide-expanding-roles-for-pas-and-nps-updated-2025/#:~:text=Full%20practice%20authority%20legislation%20reached,12
• https://natlawreview.com/article/telehealth-and-person-visits-tracking-federal-and-state-updates-pandemic-era?amp=#:~:text=coordination%20with%20the%20U,prescribing
• https://telehealth.hhs.gov/providers/telehealth-policy/prescribing-controlled-substances-via-telehealth#:~:text=The%20Drug%20Enforcement%20Administration%20,through%20December%2031%2C%202025
• https://natlawreview.com/article/telehealth-and-person-visits-tracking-federal-and-state-updates-pandemic-era?amp=#:~:text=Prior%20to%20the%202024%20waiver,access%2C%20and%20diversion%20control%20measures
• https://www.cchpca.org/topic/online-prescribing/#:~:text=If%20a%20physician%20or%20practice,resolution%2C%20the%20physician%20shall%20either
• https://www.cchpca.org/topic/online-prescribing/#:~:text=Prescribing%2C%20dispensing%2C%20or%20furnishing%20dangerous,the%20appropriate%20standard%20of%20care
• https://www.cchpca.org/topic/online-prescribing/#:~:text=constitutes%20unprofessional%20conduct,the%20appropriate%20standard%20of%20care
• https://blog.healthjobsnationwide.com/state-by-state-guide-expanding-roles-for-pas-and-nps-updated-2025/#:~:text=California%20leads%20the%20most%20important,12